Alector Inc.
ALECDrugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Aug 6, 2026
10dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
ALEC Earnings Report
EPS Est: $-0.24 | FQ end 2026-06
How ALEC's past catalysts played out
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Alector Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Alector Inc.'s (ALEC) pipeline across Phase 3, Phase 2. Its lead program is AL001 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Alector Inc.'s next FDA catalyst?→
Alector Inc.'s (ALEC) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ALEC biotech catalysts?→
Add ALEC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Alector Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.